非洲药物局:其起源,演变,机构结构和未来前景的历史视角
Alex Juma Ismail1,2, Delese Mimi Darko3, Stuart Walker1,4
1School of Health, Medicine and Life Sciences, University of Hertfordshire, Hatfield, United Kingdom.
Frontiers in medicine
|February 20, 2026
概括
非洲药物署 (AMA) 协调监管系统,以改善非洲各地获得药物的机会. 尽管面临挑战,其框架和试点项目显示出加强公共卫生的前景.
科学领域:
- 公共卫生 公共卫生
- 监管科学 监管科学
- 非洲卫生系统 非洲卫生系统
背景情况:
- 非洲分散的监管体系阻碍了获得安全医疗产品的机会.
- 2009年启动的非洲药物监管协调 (AMRH) 计划为非洲药物管理局 (AMA) 铺平了道路.
- AMA的目标是协调监管实践,提高获得优质药物的机会,并加强整个大陆的公共卫生基础设施.
研究的目的:
- 审查非洲药物局 (AMA) 的历史演变.
- 分析AMA的条约和拟议的机构框架.
- 检查操作试点项目,包括AMRH人类药品大陆清单.
主要方法:
- 进行了叙事文学评论.
- 数据来源包括非洲联盟的官方文件,同行评审的出版物和技术报告.
- 分析了2005年至2025年间出版的文献.
主要成果:
- 亚马条约于2019年通过,于2021年生效,并于2025年6月由31个非洲联盟成员国批准.
- 美国医学协会的结构包括缔约国会议,理事会,秘书处和技术委员会.
- 试点项目证明了依赖机制的可行性,但法律协调,资金和能力方面的挑战仍然存在.
结论:
- 非洲监管协会 (AMA) 标志着非洲监管趋同的重大进展.
- 已建立的条约和试点项目的结果为AMA的运营提供了坚实的基础.
- 美国医学协会 (AMA) 准备在非洲大陆显著改善医疗产品监管和公共卫生结果.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
592
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
592
Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Preclinical Development: Overview
6.1K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.1K
Drug Administration and Therapy Phases: Overview
1.5K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.5K
Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
International Nursing Organizations II
1.4K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.4K


